EP4456889A4 - Pharmazeutische zusammensetzung mit naproxen und esomeprazol - Google Patents

Pharmazeutische zusammensetzung mit naproxen und esomeprazol

Info

Publication number
EP4456889A4
EP4456889A4 EP22917068.3A EP22917068A EP4456889A4 EP 4456889 A4 EP4456889 A4 EP 4456889A4 EP 22917068 A EP22917068 A EP 22917068A EP 4456889 A4 EP4456889 A4 EP 4456889A4
Authority
EP
European Patent Office
Prior art keywords
esomeprazole
naproxen
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22917068.3A
Other languages
English (en)
French (fr)
Other versions
EP4456889A2 (de
Inventor
Udaya Kumar Dude
Nurcin Yilmaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Original Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi Ibrahim Ilac Sanayi Ve Ticaret AS filed Critical Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Priority claimed from PCT/TR2022/051640 external-priority patent/WO2023129069A2/en
Publication of EP4456889A2 publication Critical patent/EP4456889A2/de
Publication of EP4456889A4 publication Critical patent/EP4456889A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP22917068.3A 2021-12-29 2022-12-28 Pharmazeutische zusammensetzung mit naproxen und esomeprazol Pending EP4456889A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202121734 2021-12-29
PCT/TR2022/051640 WO2023129069A2 (en) 2021-12-29 2022-12-28 A pharmaceutical composition comprising naproxen and esomeprazole

Publications (2)

Publication Number Publication Date
EP4456889A2 EP4456889A2 (de) 2024-11-06
EP4456889A4 true EP4456889A4 (de) 2025-12-31

Family

ID=93014675

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22917068.3A Pending EP4456889A4 (de) 2021-12-29 2022-12-28 Pharmazeutische zusammensetzung mit naproxen und esomeprazol

Country Status (1)

Country Link
EP (1) EP4456889A4 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365184B1 (en) * 1996-01-08 2002-04-02 Astrazeneca Ab Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
CN202288921U (zh) * 2011-08-02 2012-07-04 天津市嵩锐医药科技有限公司 复方萘普生埃索美拉唑片
KR20130115593A (ko) * 2012-04-12 2013-10-22 한미약품 주식회사 비스테로이드성 항염증약물 및 프로톤 펌프 저해제를 포함하는 약제학적 복합제제 및 이의 제조방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365184B1 (en) * 1996-01-08 2002-04-02 Astrazeneca Ab Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
CN202288921U (zh) * 2011-08-02 2012-07-04 天津市嵩锐医药科技有限公司 复方萘普生埃索美拉唑片
KR20130115593A (ko) * 2012-04-12 2013-10-22 한미약품 주식회사 비스테로이드성 항염증약물 및 프로톤 펌프 저해제를 포함하는 약제학적 복합제제 및 이의 제조방법

Also Published As

Publication number Publication date
EP4456889A2 (de) 2024-11-06

Similar Documents

Publication Publication Date Title
EP4183391A4 (de) Pharmazeutische zusammensetzung und verwendung davon
EP4149470A4 (de) Pharmazeutische formulierungen und verwendungen davon
EP4074336A4 (de) Pharmazeutische zusammensetzung und verwendung davon
EP3556369A4 (de) Orale pharmazeutische zusammensetzung mit verzögerter und kontrollierter freisetzung von olaparib und deren verwendungen
EP4072520C0 (de) Pharmazeutische zusammensetzungen mit cabotegravir
EP3449944A4 (de) Oral verabreichte nanopartikel zur genverabreichung und pharmazeutische zusammensetzung damit
EP3711767C0 (de) Pharmazeutische zubereitung mit ausgezeichneter lichtstabilität und wirkstofffreisetzungseigenschaften
EP4375300A4 (de) Pharmazeutische zusammensetzung und verwendung
EP3607957A4 (de) Pharmazeutische zusammensetzung und kosmetische zusammensetzung
EP4397663A4 (de) 6-aminopyrazolopyrimidinverbindung und pharmazeutische verwendung davon
EP4398909A4 (de) Pharmazeutische zusammensetzung und verwendung davon
EP3556352A4 (de) Amphiphile blockcopolymerzusammensetzung mit verbesserter mizellenstabilität und pharmazeutische zusammensetzung damit
EP3552612A4 (de) Pharmazeutische zusammensetzung und medizinisches instrument
EP4011885A4 (de) Oxo-pyridin-fusionsringderivate und diese umfassende pharmazeutische zusammensetzung
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
EP4293045A4 (de) Pharmazeutische anti-tigit-antikörperzusammensetzung und anwendung davon
EP4037659C0 (de) Pharmazeutische zusammensetzung mit enzalutamid
EP3826627C0 (de) Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
EP3643784A4 (de) Rekombinanter humaner basischer fibroblasten-wachstumsfaktor (rh-bfgf) und pharmazeutische zusammensetzung mit rh-bfgf
EP4247335C0 (de) Pharmazeutische zusammensetzung mit cannabidiol und hyaluronsäure
EP3773654C0 (de) Pharmazeutische wirkstoffzusammensetzungen und zugehörige verfahren
EP4436580A4 (de) Pharmazeutische zusammensetzung und verwendung davon
EP3613742A4 (de) Indolizinderivate und deren anwendung in der medizin
EP4321537A4 (de) Pharmazeutische zusammensetzung und verwendung davon
EP4069233A4 (de) Pharmazeutische kombination und verwendung davon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240614

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20251202

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/192 20060101AFI20251126BHEP

Ipc: A61K 31/4439 20060101ALI20251126BHEP

Ipc: A61P 1/04 20060101ALI20251126BHEP

Ipc: A61K 9/20 20060101ALI20251126BHEP